Hypertriglyceridemia clinical trials at University of California Health
3 in progress, 1 open to eligible people
Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
open to eligible people ages 18 years and up
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.
at UCSD
Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Sorry, in progress, not accepting new patients
The purpose of the study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.
at UCSD
Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
Sorry, in progress, not accepting new patients
The purpose of the study is to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo in participants with hypertriglyceridemia and atherosclerotic cardiovascular disease, or with severe hypertriglyceridemia.
at UCLA UCSD
Last updated: